Back to Authors

Wang, Dejie

0000-0003-3870-2385

Mayo Clinic

Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905.

Citations 1

ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor–activated cancer
Tang, Bo , Wang, Dejie , Sheng, Haoyue , Wei, Ting , Wang, Liguo , Zhang, Jun , Ho, Thai H. , Yang, Lu , Wei, Qiang , Wei, Ting , Sun, Rui , Wang, Dejie , Wei, Ting , Wang, Liguo , Ho, Thai , Wei, Ting , Sun, Rui , Huang, Haojie

Proceedings of the National Academy of Sciences | February 16, 2021 | Volume: 118 | Issue: 8 | Pages: No page available

10.1073/pnas.2019052118 Get It

Significance The multiple-domain protein ZMYND8 is well known as a chromatin reader that recognizes methylated, acetylated, and/or mutated histones. Here we report that ZMYND8 is overexpressed in human ccRCC, and that it preferentially binds T487-phosphorylated EZH2. We show that in hypoxia-stimulated or von Hippel–Lindau–deficient cells, ZMYND8 binding of EZH2 is important for maintenance of EZH2 phosphorylation level, inhibition of PRC2 complex formation, and enhanced interaction between EZH2 and FOXM1. Our results reveal a reader function of ZMYND8 in recognizing a phosphorylation “code” on a nonhistone protein. Our findings also identify ZMYND8 binding as a facet of regulation and function of EZH2 phosphorylation in the Polycomb-dependent to -independent switch of EZH2/PRC2 activities.